One dose vaccination with Mycoplasma hyopneumoniae
USRE44399E1 · kind E1 · reissue
7Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2012 |
| Grant date | Jul 30, 2013 |
| Priority date | — |
| Expiry date | Mar 2, 2032 |
Classification
- Technology area (CPC —)General
Abstract
The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.